160 related articles for article (PubMed ID: 1463919)
21. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
22. Prediction of the time of ovulation.
Garcia JE; Jones GS; Wright GL
Fertil Steril; 1981 Sep; 36(3):308-15. PubMed ID: 6456939
[TBL] [Abstract][Full Text] [Related]
23. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
Lenton EA; King H; Johnson J; Amos S
Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
[TBL] [Abstract][Full Text] [Related]
24. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
25. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of the urinary luteinizing hormone surge in young ovulatory women.
Park SJ; Goldsmith LT; Skurnick JH; Wojtczuk A; Weiss G
Fertil Steril; 2007 Sep; 88(3):684-90. PubMed ID: 17434509
[TBL] [Abstract][Full Text] [Related]
27. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study.
Howards PP; Schisterman EF; Wactawski-Wende J; Reschke JE; Frazer AA; Hovey KM
Am J Epidemiol; 2009 Jan; 169(1):105-12. PubMed ID: 18974081
[TBL] [Abstract][Full Text] [Related]
28. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
29. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
30. Validation of the dual analyte assay of the oestrone:pregnanediol ratio in monitoring ovarian function.
Fabres C; Zegers-Hochschild F; Altieri E; Llados C
Hum Reprod; 1993 Feb; 8(2):208-10. PubMed ID: 8473420
[TBL] [Abstract][Full Text] [Related]
31. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Dahl KD; Czekala NM; Lim P; Hsueh AJ
J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
[TBL] [Abstract][Full Text] [Related]
32. Detection of the ovulatory luteinizing hormone (LH) surge with a semiquantitative urinary LH assay.
Knee GR; Feinman MA; Strauss JF; Blasco L; Goodman DB
Fertil Steril; 1985 Nov; 44(5):707-9. PubMed ID: 4054353
[TBL] [Abstract][Full Text] [Related]
33. Temporal relationships between indices of the fertile period.
Fertil Steril; 1983 May; 39(5):647-55. PubMed ID: 6840308
[TBL] [Abstract][Full Text] [Related]
34. Methods of monitoring menstrual function in field studies: attitudes of working women.
Wright DM; Kesner JS; Schrader SM; Chin NW; Wells VE; Krieg EF
Reprod Toxicol; 1992; 6(5):401-9. PubMed ID: 1463920
[TBL] [Abstract][Full Text] [Related]
35. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
36. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency.
Pazzagli M; Magini A; Forti G; Bolelli G; Scarselli G; Noci I; Pellegrini S; Rodbard D; Serio M
J Steroid Biochem; 1987; 27(1-3):399-404. PubMed ID: 3695488
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
38. Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women.
Luciano AA; Peluso J; Koch EI; Maier D; Kuslis S; Davison E
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):412-6. PubMed ID: 2406661
[TBL] [Abstract][Full Text] [Related]
39. Urinary endocrine monitoring of the ovarian cycle and pregnancy in Goeldi's monkey (Callimico goeldii).
Carroll JB; Abbott DH; George LM; Hindle JE; Martin RD
J Reprod Fertil; 1990 May; 89(1):149-61. PubMed ID: 2165155
[TBL] [Abstract][Full Text] [Related]
40. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
